Findlay Park Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$138M Sell
657,713
-17,042
-3% -$3.65M 1.87% 29
2026
Q1
$149M Buy
674,755
+53,203
+9% +$13M 2.08% 21
2025
Q4
$158M Sell
621,552
-125,600
-17% -$31.5M 2.01% 23
2025
Q3
$185M Sell
747,152
-13,500
-2% -$3.23M 1.94% 21
2025
Q2
$183M Sell
760,652
-27,500
-3% -$6.4M 1.88% 20
2025
Q1
$179M Buy
788,152
+10,600
+1% +$2.33M 1.84% 23
2024
Q4
$160M Buy
777,552
+193,800
+33% +$42.5M 1.59% 30
2024
Q3
$142M Sell
583,752
-6,200
-1% -$1.45M 1.34% 38
2024
Q2
$130M Sell
589,952
-4,500
-0.8% -$978K 1.22% 36
2024
Q1
$134M Sell
594,452
-10,500
-2% -$2.37M 1.23% 37
2023
Q4
$133M Buy
604,952
+113,936
+23% +$24.1M 1.31% 37
2023
Q3
$108M Sell
491,016
-4,628
-0.9% -$1.05M 1.16% 38
2023
Q2
$112M Sell
495,644
-31,103
-6% -$6.22M 1.14% 42
2023
Q1
$101M Buy
+526,747
New +$102M 1.06% 44

Other funds holding STE

Findlay Park Partners's STE Position: Q2 2026 in Review

Findlay Park Partners reduced its Steris (STE) stake by 2.5% in Q2 2026, selling an estimated $3.65M and leaving 657,713 shares worth $138M. The position accounts for 1.87% of the portfolio, ranked #29.

Findlay Park Partners first reported a position in STE in Q1 2023 and has held it in 14 quarters since. The position peaked at $185M in Q3 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Findlay Park Partners held 657,713 shares of Steris worth $138M as of Q2 2026.
  • Findlay Park Partners sold 17,042 Steris shares in Q2 2026, an estimated $3.65M.
  • Steris made up 1.87% of Findlay Park Partners's portfolio in Q2 2026, its #29 holding.
  • Findlay Park Partners first reported a position in Steris in Q1 2023 and has held it in 14 quarters since.
  • Findlay Park Partners's Steris position peaked at $185M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Findlay Park Partners's 13F filing for Q2 2026, filed 12 Aug 2026.